Alcanna Inc. ("
Alcanna") (TSX: CLIQ) and YSS Corp.
("
YSS") (TSX-V: YSS; WCN: A2PMAX; and OTCQB:
YSSCF) are pleased to announce the execution of a business
combination agreement dated January 18, 2021 (the
"
Agreement"), pursuant to which Alcanna will
spin-out its retail cannabis business and combine with YSS to
launch a new discount-focused cannabis retailer in an all-stock
transaction that will result in the reverse take-over of YSS by
Alcanna (the "
Transaction"). Eight Capital
("
Eight Capital") and Cormark Securities Inc.
("
Cormark" and together with Eight Capital, the
"
Agents"), have been engaged to lead a minimum
$25.0 million equity financing of an affiliate of Alcanna in
connection with the Transaction (the "
Concurrent
Financing").
On closing, the resulting company, which is
expected to be renamed (the "Name Change") Nova
Cannabis Inc. ("New Nova" or
"Company"), will have 53 retail locations in
Alberta, Saskatchewan and Ontario, with another 9 locations under
construction. Approximately 80% of New Nova’s locations are
expected to be re-branded as "Value Buds" and will target the
value-conscious consumer, an under-served segment of the market
that is estimated to account for approximately 70% of total
recreational cannabis market in Canada (both legal and
illicit).
The Agreement and the Concurrent Financing imply
a deemed value for New Nova of $130 million and a deemed value per
common share of YSS (each a "YSS
Share") approximately $0.1635. Closing of the
Transaction is expected to occur on or about March 1, 2021.
Completion of the Transaction is subject to customary closing
conditions and regulatory approvals, including of the TSX Venture
Exchange (the "TSXV"), completion of the
Concurrent Financing (described below), approval of the reverse
take-over and the Consolidation (described below) by the holders of
YSS Shares, and all approvals to complete the Amalgamation (as
defined below) shall have been obtained. Immediately upon
completion of the Transaction, it is expected that New Nova will
satisfy the listing requirements of a Tier 1 Life Sciences issuer
under the policies of the TSXV. It is anticipated that the Company
will apply to list on the facilities of the Toronto Stock Exchange
(the "TSX") following closing of the Transaction.
Listing on the TSX will be subject to New Nova meeting the TSX's
original listing requirements at such time.
"Selling 'value bud' is what Value Buds will be
all about. Our mission is to be disruptive; to provide consumers
with the quality products they want at discount prices, which we
believe will be lower than those offered by either the illicit
market or current legal retailers," said Darren Karasiuk, who is
expected to lead New Nova as Chief Executive Officer and establish
the Company's head office in the Greater Toronto Area. "Thanks to
Alcanna's extensive retail expertise in both cannabis and liquor
retailing, we have experience in deploying a value-focused retail
model. We believe we know where the value-conscious customers live,
work and shop and leveraging our long-standing relationships with
national landlords, we intend to build or buy stores that fit this
tested model."
"Alcanna's recent pilot project converting
several Nova Cannabis stores to a discount banner was very
successful with average sales increases of over 250%," said James
Burns, Alcanna's Vice Chair and CEO who is expected to become Chair
of New Nova. "We are confident of similar success as we convert
most of our Alberta Nova stores to Value Buds over the next few
weeks (and the YSS Alberta and Saskatchewan stores once the
Transaction closes). New Nova plans to ambitiously roll-out the
Value Buds banner across Ontario through new builds and
acquisitions - which is expected to be the core focus of our new
store growth for the foreseeable future. We expect New Nova to have
the capital and expertise to do it and do it well."
Alcanna will provide management and
administrative services to New Nova, at a cost that is anticipated
to be far less than a stand-alone company could achieve, until the
Company reaches the critical size to bring those services in-house.
Alcanna will also provide lease guarantees for the Company and make
available to New Nova an operating line of credit without standby
fees for up to $10 million at prime plus 2.75% for growth including
new store builds and acquisitions and general corporate purposes.
The operating line of credit will be drawable at New Nova's sole
discretion and will be secured by a charge on all of the personal
property of New Nova.
"YSS shareholders should be excited by this next
step. Becoming part of the Alcanna/Nova success story validates all
we have done to build YSS to date," said Theo Zunich, President and
CEO of YSS. "The Management and Board of YSS is unanimously
recommending this Transaction to the YSS shareholders as it is
expected to provide accelerated near-term and increased long-term
value accretion that would not be achievable as a standalone
company."
Transaction Terms
Alcanna has agreed to sell all of the equity
securities of its wholly-owned subsidiaries, Alcanna Cannabis
Stores GP Inc. ("ACS GP") and Alcanna Cannabis
Stores Limited Partnership ("ACS LP" and together
with ACS GP, the "ACS Entities"), which carry on
Alcanna's retail cannabis business, to YSS.
The terms of the Agreement and the Concurrent
Financing imply a deemed value for Alcanna's cannabis business of
approximately $107.25 million and a deemed value for YSS of
approximately $22.75 million, equating to an aggregate market
capitalization of New Nova following completion of the Transaction
of approximately $130 million. The Agreement and Concurrent
Financing imply a deemed value of approximately $0.1635 per YSS
Share.
Following the closing of the Transaction, but
prior to giving effect to the Concurrent Financing, the current YSS
shareholders will hold approximately 17.5% and Alcanna will hold
approximately 82.5%, respectively, of the common shares of New Nova
("Nova Shares"), calculated on a basic basis.
Pursuant to the Agreement, YSS will consolidate
(the "Consolidation") all of the issued and
outstanding YSS Shares on the basis of a ratio of approximately
0.05449-to-one, such that, after completion of the Consolidation,
YSS shareholders will hold approximately 7,583,333
post-Consolidation YSS Shares. In consideration for the purchase of
the ACS Entities from Alcanna, YSS will issue Alcanna 35,750,000
YSS Shares at a post-Consolidation deemed price of $3.00 per YSS
Share.
A waiver is being sought from the TSXV's
requirement for a sponsor to be retained in connection with the
Transaction. YSS is at arm's length to Alcanna and the Transaction
is an arm's length transaction.
Concurrent Financing
In connection with the Transaction, ACS LP,
through its wholly-owned subsidiary Alcanna Cannabis Stores Finance
Ltd. ("ACS FinCo"), will complete
a brokered private placement of at least 8,333,333 subscription
receipts of ACS FinCo (each, a "Subscription
Receipt") at a price of $3.00 per Subscription Receipt for
aggregate gross proceeds of minimum $25.0 million. Alcanna and ACS
FinCo have jointly engaged the Agents as joint bookrunners for the
Concurrent Financing pursuant to an engagement letter dated January
18, 2021 (the "Engagement Letter"). Each
Subscription Receipt will automatically convert into one common
share of ACS FinCo (each, a "FinCo Share") upon
satisfaction of the Escrow Release Conditions (described
below).
Concurrent with the closing of the Transaction,
ACS FinCo and 2316416 Alberta Ltd., a wholly-owned subsidiary of
YSS, will amalgamate (the "Amalgamation") pursuant
to the Agreement. Pursuant to the Amalgamation, each holder of
FinCo Shares issued upon conversion of the Subscription Receipts
will receive one post-Consolidation YSS Share for each FinCo Share
held. After completion of the Amalgamation and assuming the
Concurrent Financing is completed for $25.0 million, it is
anticipated that Alcanna will hold approximately 69.2%, current YSS
shareholders will hold approximately 14.7%, and new subscribers
under the Concurrent Financing will hold approximately 16.1% of the
Nova Shares, respectively, calculated on a basic basis.
The Concurrent Financing is expected to close on
or about February 5, 2021. Alcanna and YSS will each have the right
to terminate the Agreement if the Concurrent Financing does not
close prior to February 28, 2021. The gross proceeds from the sale
of the Subscription Receipts (the "Escrowed
Funds") will be held in escrow pending delivery to the
escrow agent of a certificate to the effect that: (i) all
conditions necessary to complete the Transaction have been
satisfied or waived (with the consent of the Agents) in accordance
with the Agreement; (ii) the Concurrent Financing has been
completed; and (iii) all necessary regulatory and other approvals
regarding the Transaction and the Concurrent Financing have been
obtained (the "Escrow Release Conditions"), which
conditions will be reflected in a subscription receipt agreement to
be entered into between Alcanna, ACS FinCo, YSS and the Agents on
the date of closing of the Concurrent Financing. Upon satisfaction
of the Escrow Release Conditions, the Escrowed Funds and any
interest earned thereon, less the fees payable to the Agents, will
be released to ACS FinCo. The net proceeds of the Concurrent
Financing will be used to fund the pro forma business plan of the
Company and for working capital and general corporate purposes.
If: (a) the Escrow Release Conditions are not
satisfied by 5:00 p.m. (Calgary time) on March 31, 2021, or such
later date as Alcanna, YSS and the Agents may elect; (b) the
Agreement is terminated; or (c) Alcanna has advised the Agents or
announced to the public that it does not intend to proceed with the
Transaction, holders of Subscription Receipts shall receive an
amount equal to the full subscription price attributable to the
Subscription Receipts and their pro rata entitlement to the
interest accrued on such amount.
The Agents will be entitled to receive a cash
commission equal to 6% of the aggregate gross proceeds from the
Concurrent Financing and such number of compensation warrants as is
equal to 4% of Subscription Receipts sold pursuant to the
Concurrent Financing (the "Agents Warrants") upon
completion of the Transaction. Each whole Agents Warrant will be
exercisable into one Subscription Receipt or one Nova Share, as the
case may be, for a period of 24 months following the closing of the
Concurrent Financing.
In addition, ACS FinCo has granted the Agents an
option, exercisable from time to time, in whole or in part by the
Agents, up to 48 hours prior to the closing of the Concurrent
Financing, to offer for sale up to an additional number of
Subscription Receipts equal to 25% of the Subscription Receipts
sold pursuant to the Concurrent Financing at a price of $3.00 per
additional Subscription Receipt.
YSS Shareholder Meeting and Board
Recommendation
The YSS board of directors has unanimously
determined that the Transaction and the execution of the Agreement
is in the best interests of YSS and is fair to the YSS
shareholders, and has unanimously recommended that the YSS
shareholders vote in favour of the resolutions approving the
Consolidation, Transaction and the Name Change. YSS will call a
special meeting of YSS shareholders to vote on the required matters
contemplated by the Transaction, including the approval of the
reverse take-over as required pursuant to the policies of the TSXV.
It is expected that the YSS shareholder meeting will be held on or
about March 1, 2021.
All of the directors and executive officers of
YSS representing an aggregate of 27,147,668 pre-Consolidation YSS
Shares (or approximately 20% of the issued and outstanding YSS
Shares) have entered into support agreements with Alcanna in
support of the Transaction and have agreed to irrevocably vote
their YSS Shares in favour of the matters to be considered at the
special meeting of YSS shareholders.
Cormark has provided a formal opinion that,
subject to the various factors, assumptions, qualifications and
limitations upon which the opinion is based, the consideration to
be paid by YSS pursuant to the Transaction is fair, from a
financial point of view, to the shareholders of YSS.
Further details in respect of the Transaction,
the ACS Entities the retail cannabis business of the ACS Entities,
ACS FinCo, YSS and New Nova will be included in the management
information circular to be prepared and filed with the TSXV in
respect of the YSS shareholder meeting, and in subsequent news
releases and other public filings.
About Alcanna and the ACS Entities
Alcanna, a corporation existing under the Canada
Business Corporations Act, is one of the largest private sector
retailers of alcohol and cannabis in North America and the largest
in Canada by number of stores – operating 238 locations in Alberta
and British Columbia. Alcanna is incorporated under the laws of
Canada, and its common shares and convertible subordinated
debentures trade on the Toronto Stock Exchange under the symbols
"CLIQ" and "CLIQ.DB", respectively. Additional information about
Alcanna is available at www.sedar.com and www.alcanna.com.
The ACS Entities were formed in 2018 to leverage
Alcanna's retail experience and expertise to become an industry
leader in the Canadian retail cannabis industry with a strategy to
independently open and develop its stores to increase its presence
in the recreational retail cannabis market. The ACS Entities are
operated primarily from Alcanna's head office in Edmonton, Alberta.
Alcanna opened 5 of the first 17 recreational retail cannabis
locations in Alberta on October 17, 2018. By December 31, 2019,
Alcanna had opened an additional 16 recreational retail cannabis
stores in Alberta and 1 in Ontario. These stores range in size from
1,200 to 5,600 square feet. Alcanna now operates a total of 30
cannabis retail stores under the "Nova Cannabis" brand and 4 under
the "Deep Discount Cannabis" brand, with 33 locations in Alberta
and one in Ontario. Certain financial information in respect of the
ACS Entities and the cannabis retail business for the year ended
December 31, 2019 and the nine months ended September 30, 2020 are
provided below:
|
Nine months ended September 30,
2020(Unaudited) |
Year ended December 31,
2019(Unaudited) |
Assets |
$57,627 |
$52,565 |
Liabilities |
$37,395 |
$57,204 |
Revenues |
$46,049 |
$41,114 |
Net Profit (Loss) |
$1,098 |
$(8,739) |
|
|
|
About YSS
With retail operations under the YSS™ and Sweet
Tree™ brands, YSS Corp. has developed a retail cannabis business
across Alberta and in Saskatchewan by operating 19 licensed retail
stores in Alberta and Saskatchewan. It has 5 stores in development
for 2021. YSS was continued under the laws of Alberta and has a
head office in Calgary, Alberta. The YSS Shares trade on the TSXV
under the symbol "YSS", on the Frankfurt Stock Exchange under the
symbol "WKN: A2PMAX", and over the facilities of the OTCQB Venture
Market under the symbol "YSSCF". Additional information about YSS
is available at www.sedar.com and www.ysscorp.ca.
New Nova Management
In accordance with the terms of the Agreement,
upon closing of the Transaction Alcanna and YSS will enter into an
investor rights agreement which shall provide Alcanna with the
ability to appoint four nominees to the board of directors of New
Nova upon closing of the Transaction and contain customary rights
with respect to the ownership percentage of Alcanna in the Company
upon closing. It is currently contemplated that on completion of
the Transaction and the receipt of the requisite approvals,
including of the TSXV, the board of directors of the Company will
be comprised of: James Burns, Darren Karasiuk, Ross Sinclair,
Thomas Bitove and Ron Hozjan. It is further anticipated that the
senior management of the Company will be comprised of: Darren
Karasiuk, President and Chief Executive Officer; David Gordey,
Chief Financial Officer; and Marcie Kiziak, Chief Operating
Officer. Other than Ron Hozjan, the current directors and executive
officers of YSS are expected to resign in connection with the
closing of the Transaction.
Darren Karasiuk, Director, President and
Chief Executive Officer (Toronto,
Ontario)
Mr. Karasiuk served as Chief Commercial Officer
of Aurora Cannabis Inc. ("Aurora") where he had
oversight of key customer facing and revenue driving functions,
including sales, marketing, consumer insights and analytics. During
his tenure, he helped Aurora achieve leadership in the Canadian
recreational and medical cannabis markets, as well as Europe. Mr.
Karasiuk joined Aurora through the acquisition of MedReleaf Corp.,
where he served first as Vice-President, Strategy and later as
Senior Vice-President and General Manager of the Recreational
business. Prior to joining MedReleaf, Mr. Karasiuk was
Vice-President, Insights and Advisory at Deloitte. Mr. Karasiuk has
served on Alcanna's board since 2019 and holds an MA from Western
University as well as an MBA from Kellogg-Schulich. It is
anticipated Mr. Karasiuk will resign from the Alcanna board on
closing of the Transaction.
James Burns, Chair
(Edmonton, Alberta)
Mr. Burns has been Vice-Chair and Chief
Executive Officer of Alcanna since December 2017 after joining the
board in June 2017 and being named lead director and placed in
charge of developing Alcanna's cannabis strategy. Throughout a
45-year career, he has been: a partner at Gordon Capital
Corporation and Gordon Investment Corporation in their private
equity business; co-owner, director and CFO at Scott's Restaurants
and priszm brandz; Managing Director at CIBC Capital Markets; and
Chief of Staff to the Deputy Prime Minister of Canada and Chair of
the Chiefs of Staff Committee. Mr. Burns holds a B. Comm.
(Honours) from Queen's University School of Business and a Master
of Science (Mark of Distinction) in Politics of the World Economy
from the London School of Economics.
Thomas Bitove, Director
(Toronto, Ontario)
Mr. Bitove has worked in many aspects of
multi-unit operations for his entire career. Just a few of the
businesses he has owned and operated include: Hard Rock Café; a 32
store Big Boy chain; 35 separate restaurants and concessions at
Toronto Pearson airport; and 17 Travel Centres along the 401 and
400 in Ontario. Mr. Bitove is the exclusive distributor of Red Bull
Energy Drink in Ontario and British Columbia and owner of ColdHaus
Direct Inc, a major distributor of beer and wine in Ontario. Mr.
Bitove served 12 years on the board of Intrinsyc Technologies, a
TSX-listed public company. Mr. Bitove was invested into the Order
of Ontario, Ontario's highest honour for a citizen. The award
recognizes his charitable contributions to the people of Ontario
and Canada as well as his business successes.
Ross Sinclair, Director
(Toronto, Ontario)
Mr. Sinclair was a partner with
PricewaterhouseCoopers LLP ("PwC") and has more
than 25 years of experience as a partner. Mr. Sinclair retired from
PwC on June 30, 2020. He has had extensive experience with clients
across several industries including consumer products, retail, real
estate, health care and private equity. Mr. Sinclair has served
many clients advising on critical business issues, transactions and
restructurings in addition to his experience as a lead audit
partner on both public and private enterprises. Mr. Sinclair's
experience includes PwC Canada leadership roles as Income Trust and
IPO Services Group Leader, as well as Retail & Consumer
Products National and GTA Industry Leader. Mr. Sinclair has
significant experience working with clients on their capital
markets projects and needs, including numerous equity, debt and
initial public offering and RTOs. Mr. Sinclair has also served as
the overall audit engagement leader on several Canadian retailers
and other public companies including both US GAAP, SEC, OSC and
IFRS reporting responsibilities. Mr. Sinclair was a designated
Trustees on the Continuum REIT IPO in the fall of 2019 and is an
Advisory Board member and investor in Arch Corporation.
Ron Hozjan, Director
(Calgary, Alberta)
Mr. Hozjan has served as a director of YSS since
June 2018 and is currently a member of YSS' audit committee and
corporate governance and compensation committee. Since January
2020, Mr. Hozjan has held the role of Vice President, Finance and
Chief Financial Officer of Aureus Energy Services Inc. Prior
thereto, he served as Vice President, Finance and Chief Financial
Officer of Tamarack Valley Energy Ltd. (TSX: TVE) from June 2010
until January 2020. Mr. Hozjan has also served as a director of
Aloha Brands Inc. since April 2019.
Marcie Kiziak, Chief Operating Officer
(Edmonton, Alberta)
Ms. Kiziak, currently President of Alcanna's
cannabis division, has led the retail cannabis business since she
took over in July 2018. Ms. Kiziak was Alcanna's lead executive in
designing and executing the strategy to launch the Nova brand,
starting with 5 stores at legalization day. Ms. Kiziak has led the
growth in the business to Nova's current 34 stores. Ms. Kiziak
joined Alcanna in February 2018 as Senior Vice President, Human
Resources and continues in that role concurrently with running
Nova. Prior to joining Alcanna, Ms. Kiziak was the Vice President
of Human Resources and Safety for Corrosion and Abrasion Solutions
Ltd. from 2013 until 2017 which included a secondment into
operations to lead a business transformation. Ms. Kiziak also spent
15 years in the oil and gas and construction sectors focused on
senior HR Leadership, M&A and Integration. Ms. Kiziak holds a
Bachelor of Management Degree with a Major in Human Resources and
is a Chartered Professional in Human Resources.
David Gordey, Chief Financial Officer
(Edmonton, Alberta)
It is the intention of Alcanna that Mr. Gordey
will act as Chief Financial Officer of the Company and will also
continue in his position of Executive Vice President, Corporate
Services and Chief Financial Officer of Alcanna. Mr. Gordey assumed
the role of Executive Vice President, Corporate Services and Chief
Financial Officer of Alcanna in April 2018. Mr. Gordey served as
Chief Operating Officer, Liquor from July 2016 to April 2018, and
Senior Vice President and Chief Financial Officer from May 2014 to
July 2016, after joining Liquor Stores N.A. Ltd. in March 2012 as
Vice President, Finance. Mr. Gordey is a Chartered Professional
Accountant, formerly of KPMG LLP (Edmonton).
Advisors
Eight Capital is acting as exclusive financial
advisor to Alcanna with respect to the Transaction. Cormark is
acting as financial advisor to YSS with respect the
Transaction.
Bennett Jones LLP is acting as legal advisor to
Alcanna, Stikeman Elliott LLP is acting as legal advisor to YSS and
Torys LLP is acting as legal advisor to the Agents.
This press release does not constitute an offer
to sell or the solicitation of an offer to buy any securities in
any jurisdiction in which such offer, solicitation or sale may
would be unlawful including but not limited to in the United
States. The Subscription Receipts, FinCo Shares and the YSS Shares
have not been and will not be registered under the United States
Securities Act of 1933 (the "U.S. Securities
Act"), as amended, or any applicable securities laws of
the United States, and may not be offered, sold or delivered,
directly or indirectly, in the United States or to, or for the
account or benefit of, U.S. persons, except pursuant to an
exemption from the registrations requirements of the U.S.
Securities Act and all applicable securities laws of the United
States. "United States" and "U.S. person" are as defined in
Regulation S under the U.S. Securities Act.
NEITHER TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.
Completion of the Transaction is subject to a
number of conditions, including but not limited to, acceptance of
the TSXV and approval of the YSS shareholders. The Transaction
cannot close until the required shareholder approval is obtained.
There can be no assurance that the Transaction will be completed as
proposed or at all. Investors are cautioned that, except as
disclosed in the management information circular to be prepared in
connection with the Transaction, any information released or
received with respect to the Transaction may not be accurate or
complete and should not be relied upon. Trading in the securities
of YSS should be considered highly speculative. The TSX Venture
Exchange Inc. has in no way passed upon the merits of the proposed
transaction and has neither approved nor disapproved the contents
of this news release.
NOTE REGARDING FORWARD-LOOKING INFORMATION
This press release contains certain
"forward-looking information" and certain "forward-looking
statements" within the meaning of applicable securities laws, such
as statements and information concerning anticipated future events,
results, circumstances, performance or expectations that are not
historical facts or information or current condition, but instead
represent only the parties beliefs regarding future events, plans
or objective, many of which, by their nature, are inherently
uncertain and outside of the Alcanna, YSS or the Company's control.
Use of words such as "may", "will", "expect", "plans", "could",
"would", "might", "believe", "intends", "likely", or other words of
similar effect may indicate a "forward-looking" statement. The
forward-looking information and forward-looking statements
contained herein may include, but are not limited to, information
concerning the Transaction and the Concurrent Financing;
expectations whether Transaction will be consummated, including
satisfaction of the Escrow Release Conditions and other conditions
precedent to the consummation of the Transaction will be satisfied;
the timing for holding the special meeting of shareholders of YSS
and the timing for completing the Transaction; expectations for
approval of the reverse take-over, Consolidation and Name Change by
the YSS shareholders; expectations for the effects of the
Transaction or the ability of the Company to successfully achieve
business objectives; expectations regarding entering into a
subscription receipt agreement and timing thereof and completion of
the Concurrent Financing; expectations for obtaining approval of
the TSXV for the Transaction and the Concurrent Financing
(including the Agents Warrants); expectations regarding the
application for listing of Nova Shares on the TSX upon completion
of the Transaction; expectations regarding the ability for New Nova
to meet the TSX original listing requirements for listing of Nova
Shares on the TSX following completion of the Transaction;
expectations regarding the investor rights agreement between
Alcanna and YSS, including the composition of the board of
directors and management of the Company following closing;
expectations regarding the market capitalization of the combined
company; expectations regarding Alcanna providing management and
administrative services to New Nova; expectations regarding the pro
forma business plan of New Nova, including plans to convert stores
in Alberta and Saskatchewan to Value Buds and roll-out the Value
Buds banner across Ontario through new builds and acquisitions, and
use of proceeds from the Concurrent Financing; expectations
regarding completion of the Amalgamation, and the issuance of Nova
Shares upon completion of the Transaction pursuant to the
Amalgamation; and expectations regarding a pledge of the assets of
New Nova to secure the operating line of credit provided by
Alcanna. These statements are not guarantees of future performance
and are subject to numerous risks and uncertainties, including
those described in the publicly filed documents of Alcanna or YSS
(available on SEDAR at www.sedar.com).
Among the key risks and uncertainties that could
cause actual results to differ materially from those projected in
the forward-looking information and statements include, but not are
limited to, the following: the ability to complete the Transaction
and the Concurrent Financing; the timing of the closing of the
Transaction and the Concurrent Financing; the ability obtain the
requisite regulatory approvals and the satisfaction of other
conditions to the Closing of the Transaction on the proposed terms
and schedule; the ability to satisfy the conditions to the
consummation of the Concurrent Financing or to the conversion of
the Subscription Receipts; the potential impact of the announcement
or consummation of the Transaction on relationships, including with
regulatory bodies, employees, suppliers, customers and competitors;
changes in general economic, business and political conditions,
including changes in the financial markets; changes in applicable
laws; compliance with extensive government regulation; and the
diversion of management time on the Transaction and the Concurrent
Financing; risks relating to the COVID-19 pandemic, governmental
responses thereto, measures taken by Alcanna or YSS in response
thereto and the impact thereof on the global economy, capital
markets, the cannabis retail industry and Alcanna, YSS and the
Company.
These statements are made as of the date of this
news release and, except as required by applicable law, neither
Alcanna nor YSS undertake any obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events or otherwise. Additionally, neither
Alcanna nor YSS undertake an obligation to comment on analyses,
expectations or statements made by third parties in respect of
Alcanna or YSS, or their respective financial or operating results
or its securities. Readers cannot be assured that the Concurrent
Financing or the Transaction will be completed on the terms
described above, or at all. Alcanna and YSS do not assume any
obligation to update or revise any forward-looking statements,
whether written or oral, that may be made from time to time by the
Alcanna or YSS on the behalf of Alcanna, YSS or the Company, except
as required by applicable law.
Readers are cautioned that the foregoing lists
of factors are not exhaustive. Additional information on these and
other factors that could affect operations or financial results of
Alcanna and YSS are included in reports on file with applicable
securities regulatory authorities and may be accessed through the
SEDAR website (www.sedar.com). These forward-looking statements are
made as of the date of this press release and Alcanna and YSS
disclaim any intent or obligation to update publicly any
forward-looking information, whether as a result of new
information, future events or results or otherwise, other than as
required by applicable securities laws.
This press release contains future-oriented
financial information and financial outlook information
(collectively, "FOFI") about the Company's pro
forma expected market capitalization and growth, which are subject
to the same assumptions, risk factors, limitations, and
qualifications as set forth in the above paragraphs. The actual
results of operations of the Company and the resulting financial
results will likely vary from the amounts set forth in this
presentation and such variation may be material. Alcanna, YSS and
their respective management believe that the FOFI has been prepared
on a reasonable basis, reflecting management's best estimates and
judgments. However, because this information is subjective and
subject to numerous risks, it should not be relied on as
necessarily indicative of future results. Except as required by
applicable securities laws, Alcanna and YSS undertake no obligation
to update such FOFI. FOFI contained in this press release was
approved by management of Alcanna and YSS, respectively, as of the
date of this press release and was provided for the purpose of
providing further information about the Company's anticipated
future business operations. Readers are cautioned that the FOFI
contained in this press release should not be used for purposes
other than for which it is disclosed herein.
FOR FURTHER INFORMATION PLEASE CONTACT:
For Alcanna:James BurnsVice-Chair and Chief
Executive Officer
(587) 460-1026
For New Nova: Darren
KarasiukChief Executive Officer (as of closing)(416) 580-8768
For YSS:Theo ZunichPresident,
Chief Executive Officer and Director(403) 455-7656
YSS (TSXV:YSS)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
YSS (TSXV:YSS)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024